Skip to contentApplication 761215
- Type
- BLA
- Sponsor
- ELI LILLY CO
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | REZVOGLAR | INSULIN GLARGINE-AGLR | INJECTABLE;INJECTION | 3ML(100UNITS/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0002-8980 | Rezvoglar | Insulin glargine-aglr | Eli Lilly and Company | BLA | Current |
| 0002-8980 | Rezvoglar | Insulin glargine-aglr | Eli Lilly and Company | BLA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 79376 | SUPPL | 2024-08-12 |
| 79367 | SUPPL | 2024-08-12 |
| 73009 | ORIG | 2022-12-22 |
| 72635 | ORIG | 2022-11-17 |
| 72622 | ORIG | 2022-11-16 |
| 69987 | ORIG | 2022-01-28 |
| 69724 | ORIG | 2021-12-21 |
| 69637 | ORIG | 2021-12-19 |